Bio-Rad Labs (BIO) Reports Q4 EPS of $1.68

Bio-Rad Labs (NYSE: BIO) reported Q4 EPS of $1.68, does not compare to the analyst estimate of $1.27. Revenue for the quarter came in at $570.6 million versus the consensus estimate of $570.8 million.

For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• Vislink Technologies Inc. (VISL) Misses Q2 EPS by 7c
• Yum! Brands (YUM) PT Lowered to $180 at Argus